Skip to main content
. Author manuscript; available in PMC: 2021 Aug 11.
Published in final edited form as: Nat Cancer. 2020 Sep 7;1(9):909–922. doi: 10.1038/s43018-020-00109-0

Figure 6. Residual cBAF complexes secondary to ARID1A/B loss do not possess neo-functionality.

Figure 6.

a. Gel filtration chromatography of control H2.35 cell nuclear extracts using a Superose-6 column.

b. Gel filtration chromatography of ARID1-less H2.35 cell nuclear extracts.

c. Quantification of western blot data in a and b.

d. Cation exchange chromatography of control H2.35 nuclear extracts using an S-column.

e. Cation exchange chromatography of ARID1-less H2.35 nuclear extracts.

f. Quantification of western blot data in d and e.

g. Cation exchange chromatography of MFE-296 nuclear extracts and the corresponding quantification.

h. Model for three types of subcomplexes resulting from cBAF dissociation in the absence of ARID1 paralogs. The ARID1-less cBAF specific subunit BAF45d is circled in red.

i. Expression of Ty1 tagged BAF45d in control H2.35 cells.

j. Expression of Ty1 tagged BAF45d in ARID1-less H2.35 cells. The expression level was compared with endogenous BAF45d in WT extracts due to partial loss of endogenous BAF45d in ARID1-less cells.

k. The occupancies of BAF45d in control and ARID1-less cells, which represent control cBAF and ARID1-less cBAF complex binding, shown as a heatmap. ARID1A binding loci were used as a reference.

l. The corresponding averaged ChIP-seq peaks and Venn diagram are shown.

m. Representative genome browser tracks showing impaired binding of ARID1-less cBAF (BAF45d peaks in ARID1-less cells).